|4/AApr 20, 4:44 PM ET

VIVUS INC 4/A

4/A · VIVUS INC · Filed Apr 20, 2016

Insider Transaction Report

Form 4/AAmended
Period: 2015-01-01
Day Wesley
VP, Clinical Research
Transactions
  • Sale

    Common Stock

    2015-01-01$3.04/sh2,549$7,74946,569 total
Footnotes (1)
  • [F1]Sold to pay the tax liability resulting from the vesting of 6,000 restricted stock units granted on January 22, 2014.

Documents

1 file
  • 4
    edgar.xml

    PRIMARY DOCUMENT